Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Denison Mines Corp Ordinary Shares (Canada) (DNN) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance

Denison Mines Corp Ordinary Shares (Canada)Trade
IDEXX Laboratories, Inc.Trade

Price performance (Past 24H)

Key statistics

Denison Mines Corp Ordinary Shares (Canada) vs IDEXX Laboratories, Inc. — how do they compare? Denison Mines Corp Ordinary Shares (Canada) trades at $2.43 (market cap $2.33B), while IDEXX Laboratories, Inc. trades at $512.76 (market cap $39.92B). The key difference: IDEXX Laboratories, Inc. is far larger — about 17.1× Denison Mines Corp Ordinary Shares (Canada)'s market cap, and IDEXX Laboratories, Inc. is more actively traded (715,982 versus 20,155,849). Which is the better fit depends on your goals — on Pluang, investors hold Denison Mines Corp Ordinary Shares (Canada) for 0 Days and IDEXX Laboratories, Inc. for 46 Days on average.

DNNIDXX
Market Cap
$2.33B$39.92B
Volume
20,155,849715,982
Sector
EnergyHealth
52-Week High
$4.37$766.68
52-Week Low
$2.27$504.70
Typical Hold Time
0 Days46 Days
Enterprise Value
$2.17B$40.82B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Denison Mines Corp Ordinary Shares (Canada)

No Aura AI signal available yet.

IDEXX Laboratories, Inc.

IDEXX Laboratories (IDXX) trades at $513.14, down 0.44% with bearish technical signals despite strong fundamentals. The company demonstrates robust revenue growth, expanding from $3.4B in 2022 to $4.3B in 2025, with net income reaching $1.06B. Recent acquisitions like CoVetAI and diagnostic platform expansions highlight strategic growth initiatives. Technical indicators show oversold conditions with RSI at 26.58, while moving averages signal bearish momentum. Analyst consensus remains optimistic with a $665 price target representing 30% upside potential.

The outlook remains positive given strong earnings beats, expanding profit margins, and strategic acquisitions. However, risks include technical weakness, FX headwinds, and competitive pressures. With 56.5% analyst buy ratings and institutional accumulation, IDXX offers growth potential but requires monitoring of technical support levels near $492-$502 for entry opportunities.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

DNN
100% Buy0% Sell
Avg holding period · 0 Days
IDXX

No sentiment data available yet.

About Denison Mines Corp Ordinary Shares (Canada)

Denison Mines is a uranium mining, development, and exploration company focused on Canada's Athabasca Basin. Its portfolio includes the Wheeler River project and interests in other uranium projects and processing facilities.

Read more on DNN →

About IDEXX Laboratories, Inc.

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.

Read more on IDXX →